MAPK8 and glioblastoma: Dual β1-integrin/JNK inhibition through AIIB2 and the JNK inhibitor SP600125 in vitro and in vivo resulted in a superior effect when combined with radiation as compared to single inhibition, i.e., increasing the median survival of orthotopic, radiochemotherapy-treated GBM mice.